DUBLIN 2, Ireland (AP) _ Horizon Therapeutics Public Limited Company (HZNP) on Wednesday reported second-quarter net income of $61 million.

The Dublin 2, Ireland-based company said it had profit of 26 cents per share. Earnings, adjusted for non-recurring costs, came to $1.07 per share.

The results fell short of Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $1.35 per share.

The drugmaker posted revenue of $876.4 million in the period, which also missed Street forecasts. Seven analysts surveyed by Zacks expected $938.8 million.

Horizon Therapeutics expects full-year revenue in the range of $3.53 billion to $3.6 billion.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HZNP at https://www.zacks.com/ap/HZNP

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News